Autres langues ImmuCell Corporation

Actions

ICCC

US4525253062

Marché Fermé - Nasdaq Autres places de cotation 22:30:01 10/05/2024			Varia. 5j.	Varia. 1 janv.
5,44 ^USD	+2,84%		+8,15%	+6,88%

02/04	Les actions d'ImmuCell chutent après le dépôt d'une déclaration d'enregistrement pour la vente de 20 millions de dollars de titres mixtes	MT
28/02	Transcript : ImmuCell Corporation, Q4 2023 Earnings Call, Feb 28, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024	08/05
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024	09/04
Immucell Corporation Reports Unaudited Sales Results for the Three Months and Twelve Months Ended March 31, 2024	09/04
ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing	02/04
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	27/02
ImmuCell Corporation Enters into an Allonge to and Amendment of Line of Credit with Gorham Savings Bank	27/02
ImmuCell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
ImmuCell Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/02
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023	16/02
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023	08/01
ImmuCell Corporation Announces Unaudited Sales Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/01
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023	13/11
ImmuCell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023	07/11
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023	05/10/23
Immucell Corporation Reports Preliminary Unaudited Sales Results for the Third Quarter, Nine Months and Trailing Twelve Months Ended September 30, 2023	05/10/23
ImmuCell Announces Submission of CMC Technical Section to the FDA	29/08/23
ImmuCell : August 2023 Corporate Presentation	10/08/23
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023	10/08/23
ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues ImmuCell Corporation

Actions

ICCC

US4525253062

Autres langues

Filtres